Related Experiment Video
Updated: Nov 17, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Beware the inhaled steroids or corticophobia?
Dimos K Gidaris1, Stella Stabouli2, Andrew Bush3
1University of Nicosia Medical School, Cyprus / Aristotle University of Thessaloniki, Thessaloniki, Greece.
Inhaled corticosteroids are vital for asthma control, offering significant benefits despite potential side effects. Addressing parental fears, or "corticophobia," is crucial for effective asthma management and patient well-being.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Pharmacology
Background:
- Inhaled corticosteroids (ICS) are foundational treatments for allergic and atopic asthma.
- Despite their efficacy and safety, parental concerns about ICS side effects persist globally.
- These concerns, termed "corticophobia," can impede optimal asthma management.
Purpose of the Study:
- To review the local and systemic side effects associated with inhaled corticosteroids.
- To investigate the prevalence and characteristics of parental "corticophobia" worldwide.
- To emphasize the importance of physician communication in addressing these fears.
Main Methods:
- Literature review of inhaled corticosteroid side effects.
- Analysis of studies reporting parental fears regarding ICS use.
- Synthesis of data on the impact of corticophobia on asthma management.
Main Results:
- Inhaled corticosteroids have a well-established safety profile with manageable side effects.
- Parental fears regarding ICS are prevalent across diverse geographical regions.
- Misconceptions about ICS contribute significantly to treatment adherence challenges.
Conclusions:
- Physicians must actively address parental "corticophobia" by providing clear, evidence-based information.
- Emphasizing the benefits and safety of ICS is essential for improving asthma control.
- Overcoming parental fears can lead to better therapeutic outcomes in asthma patients.
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Inhaled Medications
COPD: Management Using Bronchodilators and Corticosteroids
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

